miDiagnostics aims to bring clinical, blood-based diagnostics to the people who need it the most: the patients. Based around a disruptive silicon-based nanofluidic processor embedded in a low-cost test strip, miDiagnostics is building the lab test of the future. The company is making game-changing technological developments with on-chip detection of cells, proteins, nucleic acids, and/or small molecules with immediate results.
miDiagnostics was founded in 2015 as a cooperation between Imec, Johns Hopkins University, Alychlo and two other investors.
For more information: www.midiagnostics.com